Kezar Life Sciences, Inc. (KZR)

Exchange NASDAQ
6.04


Currency in USD (Disclaimer)
Volume:
Day's Range:

KZR Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-16 Kauffman Michael director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-06-16 Wallace Courtney director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-06-16 Klearman Micki director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-06-16 Garner Elizabeth director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-06-16 BERGER FRANKLIN M director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-06-16 COOPER GRAHAM K director 26,000.0 A-Award A 26,000.0 4.80 124,800.00
2022-05-12 COOPER GRAHAM K director 26,000.0 A-Award A 26,000.0 5.52 143,520.00
2022-03-21 BERGER FRANKLIN M director 890,691.0 P-Purchase A 20,000.0 14.77 295,400.00
2022-03-18 BERGER FRANKLIN M director 870,691.0 P-Purchase A 45,000.0 17.00 765,000.00
2022-03-18 BERGER FRANKLIN M director 825,691.0 P-Purchase A 15,000.0 15.96 239,400.00
2022-01-05 Henig Noreen officer: Chief Medical Officer 180,000.0 A-Award A 180,000.0 14.55 2,619,000.00
2022-01-05 Fowler John Franklin director, officer: CEO 500,000.0 A-Award A 500,000.0 14.55 7,275,000.00
2022-01-05 Kirk Christopher J. director, officer: President and CSO 170,000.0 A-Award A 170,000.0 14.55 2,473,500.00
2022-01-05 Belsky Marc officer: CFO 140,000.0 A-Award A 140,000.0 14.55 2,037,000.00
2022-01-03 Kauffman Michael director 3,896.0 M-Exempt D 5,000.0 5.91 29,550.00
2022-01-03 Kauffman Michael director 63,690.0 S-Sale D 5,000.0 16.45 82,250.00
2022-01-03 Kauffman Michael director 68,690.0 M-Exempt A 5,000.0 5.91 29,550.00
2021-12-14 Fowler John Franklin director, officer: CEO 82,721.0 M-Exempt D 7,700.0 0.90 6,930.00
2021-12-14 Fowler John Franklin director, officer: CEO 366,904.0 M-Exempt A 7,700.0 0.90 6,930.00
2021-12-09 Wallace Courtney director 52,000.0 A-Award A 52,000.0 13.87 721,240.00
2021-09-22 BERGER FRANKLIN M director 0.0 M-Exempt D 8,896.0 5.60 49,817.60
2021-09-22 BERGER FRANKLIN M director 810,691.0 M-Exempt A 8,896.0 5.60 49,817.60
2021-09-21 BERGER FRANKLIN M director 801,795.0 M-Exempt A 8,896.0 7.63 67,876.48
2021-09-21 BERGER FRANKLIN M director 792,899.0 M-Exempt A 8,896.0 5.91 52,575.36
2021-06-28 Sommadossi Jean-Pierre director 26,000.0 A-Award A 26,000.0 5.59 145,340.00
2021-06-28 Kauffman Michael director 26,000.0 A-Award A 26,000.0 0.00 0.00
2021-06-28 COOPER GRAHAM K director 26,000.0 A-Award A 26,000.0 0.00 0.00
2021-06-28 Dinges Jason director 26,000.0 A-Award A 26,000.0 0.00 0.00
2021-06-28 Klearman Micki director 26,000.0 A-Award A 26,000.0 5.59 145,340.00
2021-06-28 Garner Elizabeth director 26,000.0 A-Award A 26,000.0 0.00 0.00
2021-06-28 BERGER FRANKLIN M director 26,000.0 A-Award A 26,000.0 5.59 145,340.00
2021-06-01 Klearman Micki director 52,000.0 A-Award A 52,000.0 5.94 308,880.00
2021-01-08 Fowler John Franklin director, officer: CEO 1,200,000.0 A-Award A 1,200,000.0 0.00 0.00
2021-01-08 Belsky Marc officer: CFO 220,000.0 A-Award A 220,000.0 0.00 0.00
2021-01-08 Economides Vassiliki officer: SVP, Strategy & External Aff. 110,000.0 A-Award A 110,000.0 0.00 0.00
2021-01-08 Henig Noreen officer: Chief Medical Officer 280,000.0 A-Award A 280,000.0 0.00 0.00
2021-01-08 Kirk Christopher J. director, officer: President and CSO 260,000.0 A-Award A 260,000.0 0.00 0.00
2020-12-31 Fowler John Franklin director, officer: CEO 359,204.0 M-Exempt A 16,000.0 0.90 14,400.00
2020-12-31 Fowler John Franklin director, officer: CEO 90,421.0 M-Exempt D 16,000.0 0.90 14,400.00
2020-06-24 BERGER FRANKLIN M director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-24 Dinges Jason director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-24 Garner Elizabeth director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-24 Sommadossi Jean-Pierre director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-24 COOPER GRAHAM K director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-24 Kauffman Michael director 8,896.0 A-Award A 8,896.0 0.00 0.00
2020-06-11 BERGER FRANKLIN M director 784,003.0 P-Purchase A 100,000.0 5.50 550,000.00
2020-06-11 Equal Talent Investments Ltd 10 percent owner 6,254,545.0 P-Purchase A 1,454,545.0 5.50 7,999,997.50
2020-05-01 Henig Noreen officer: Chief Medical Officer 300,000.0 A-Award A 300,000.0 0.00 0.00
2020-02-04 Morningside Venture Investments Ltd 10 percent owner 6,109,052.0 P-Purchase A 3,800,000.0 0.00 0.00
2020-02-04 Kirk Christopher J. director, officer: President and CSO 342,609.0 P-Purchase A 38,461.0 0.00 0.00
2020-02-04 BERGER FRANKLIN M director 684,003.0 P-Purchase A 120,846.0 0.00 0.00
2020-02-04 Economides Vassiliki officer: SVP, Strategy & External Aff. 7,570.0 P-Purchase A 5,769.0 0.00 0.00
2020-02-04 Belsky Marc officer: CFO 15,384.0 P-Purchase A 15,384.0 0.00 0.00
2020-02-04 Fowler John Franklin director, officer: CEO 38,461.0 P-Purchase A 38,461.0 0.00 0.00
2020-01-12 Economides Vassiliki officer: SVP, Strategy & External Aff. 62,500.0 A-Award A 62,500.0 0.00 0.00
2020-01-12 Kirk Christopher J. director, officer: President and CSO 125,000.0 A-Award A 125,000.0 0.00 0.00
2020-01-12 Fowler John Franklin director, officer: CEO 200,000.0 A-Award A 200,000.0 0.00 0.00
2020-01-12 Belsky Marc officer: CFO 90,000.0 A-Award A 90,000.0 0.00 0.00
2019-12-19 Fowler John Franklin director, officer: CEO 346,954.0 M-Exempt A 50,000.0 0.00 0.00
2019-12-19 Fowler John Franklin director, officer: CEO 106,421.0 M-Exempt D 50,000.0 0.00 0.00
2019-12-18 Garner Elizabeth director 17,793.0 A-Award A 17,793.0 0.00 0.00
2019-11-13 Belsky Marc officer: CFO 2,000.0 P-Purchase A 800.0 0.00 0.00
2019-10-10 Fowler John Franklin director, officer: CEO 296,954.0 P-Purchase A 1,000.0 0.00 0.00
2019-09-06 Economides Vassiliki officer: SVP, Strategy & External Aff. 35,000.0 A-Award A 35,000.0 3.38 118,300.00
2019-09-06 Belsky Marc officer: CFO 60,000.0 A-Award A 60,000.0 0.00 0.00
2019-08-20 Belsky Marc officer: CFO 1,200.0 P-Purchase A 200.0 4.42 884.00
2019-08-20 Economides Vassiliki officer: SVP, Strategy & External Aff. 1,801.0 P-Purchase A 350.0 0.00 0.00
2019-08-13 Kirk Christopher J. director, officer: President and CSO 302,934.0 P-Purchase A 5,000.0 0.00 0.00
2019-08-13 Fowler John Franklin director, officer: CEO 295,954.0 P-Purchase A 2,000.0 0.00 0.00
2019-08-09 Fowler John Franklin director, officer: CEO 293,204.0 P-Purchase A 500.0 0.00 0.00
2019-08-09 Fowler John Franklin director, officer: CEO 293,954.0 P-Purchase A 750.0 0.00 0.00
2019-08-09 Belsky Marc officer: CFO 1,000.0 P-Purchase A 500.0 0.00 0.00
2019-08-09 Kirk Christopher J. director, officer: President and CSO 297,934.0 P-Purchase A 5,000.0 0.00 0.00
2019-08-09 Economides Vassiliki officer: SVP, Strategy & External Aff. 1,451.0 P-Purchase A 1,020.0 0.00 0.00
2019-07-26 Belsky Marc officer: CFO 500.0 P-Purchase A 56.0 0.00 0.00
2019-07-25 Belsky Marc officer: CFO 444.0 P-Purchase A 444.0 0.00 0.00
2019-07-22 Economides Vassiliki officer: SVP, Strategy & External Aff. 431.0 P-Purchase A 431.0 0.00 0.00
2019-06-25 Kauffman Michael director 8,896.0 A-Award A 8,896.0 7.63 67,876.48
2019-06-25 Dinges Jason director 8,896.0 A-Award A 8,896.0 0.00 0.00
2019-06-25 COOPER GRAHAM K director 8,896.0 A-Award A 8,896.0 7.63 67,876.48
2019-06-25 BERGER FRANKLIN M director 8,896.0 A-Award A 8,896.0 0.00 0.00
2019-06-25 Sommadossi Jean-Pierre director 8,896.0 A-Award A 8,896.0 0.00 0.00
2019-05-30 Economides Vassiliki officer: SVP, Strategy & External Aff. 11,320.0 P-Purchase A 750.0 0.00 0.00
2019-03-04 Economides Vassiliki officer: SVP, Strategy & External Aff. 70,000.0 A-Award A 70,000.0 0.00 0.00
2019-01-06 Belsky Marc officer: CFO 60,000.0 A-Award A 60,000.0 0.00 0.00
2019-01-06 Fowler John Franklin director, officer: CEO 175,000.0 A-Award A 175,000.0 22.85 3,998,750.00
2019-01-06 Goel Niti officer: Chief Medical Officer 75,000.0 A-Award A 75,000.0 0.00 0.00
2019-01-06 Kirk Christopher J. director, officer: President and CSO 87,500.0 A-Award A 87,500.0 0.00 0.00
2018-06-25 Aberdare Management Company, LLC 10 percent owner 105,162.0 C-Conversion A 105,162.0 0.00 0.00
2018-06-25 Aberdare Management Company, LLC 10 percent owner 136,643.0 C-Conversion A 31,481.0 0.00 0.00
2018-06-25 Aberdare Management Company, LLC 10 percent owner 0.0 C-Conversion D 105,162.0 0.00 0.00
2018-06-25 Kirk Christopher J. director, officer: President and CSO 26,690.0 A-Award A 26,690.0 5.91 157,737.90
2018-06-25 Fowler John Franklin director, officer: CEO 88,967.0 A-Award A 88,967.0 0.00 0.00
2018-06-25 Sommadossi Jean-Pierre director 143,182.0 C-Conversion A 52,581.0 0.00 0.00
2018-06-25 Sommadossi Jean-Pierre director 0.0 C-Conversion D 52,581.0 0.00 0.00
2018-06-25 Sommadossi Jean-Pierre director 178,440.0 C-Conversion A 35,258.0 0.00 0.00
2018-06-25 Morningside Venture Investments Ltd 10 percent owner 2,059,052.0 C-Conversion A 1,007,422.0 0.00 0.00
2018-06-25 Morningside Venture Investments Ltd 10 percent owner 1,051,630.0 C-Conversion A 1,051,630.0 0.00 0.00
2018-06-25 Morningside Venture Investments Ltd 10 percent owner 0.0 C-Conversion D 1,051,630.0 0.00 0.00
2018-06-25 Morningside Venture Investments Ltd 10 percent owner 2,309,052.0 P-Purchase A 250,000.0 15.00 3,750,000.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.